← All Investors
XTL BIOPHARMACEUTICALS LTD
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | SOLD OUT | −$44K | ~$0.58 |
| Q4 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$44K | ~$0.58 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$31K | ~$1.24 |
| Q1 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$31K | ~$1.24 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$36K | ~$2.37 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$36K | ~$2.37 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q4 2025 | 1 | 75,866 | +200.9% | $44K | $0.58 |
| Q1 2025 | 1 | 25,211 | +63.3% | $31K | $1.24 |
| Q2 2024 | 1 | 15,435 | — | $36K | $2.37 |